Erratum: Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis (Transplantation Proceedings (2016) 48(2) (402–407)(S0041134516000610)(10.1016/j.transproceed.2015.12.040));Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis

Transplantation Proceedings

Volumn 48, Issue 2, 2016, Pages 402-407

  Scaldaferri, F ^a   Pecere, S ^a   Petito, V ^a   Zambrano, D ^a   Fiore, L ^a   Lopetuso, L R ^a   Schiavoni, E ^a   Bruno, G ^a   Gerardi, V ^a   Laterza, L ^a   Pizzoferrato, M ^a   Ianiro, G ^a   Stojanovic, J ^a   Poscia, A ^a   Papa, A ^a   Sterbini, F P ^a   Sanguinetti, M ^a   Masucci, L ^a   Cammarota, G ^a   Gasbarrini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT;

ARTICLE; BACTEROIDETES; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; DONOR SELECTION; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FIRMICUTES; HUMAN; INTESTINE FLORA; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ULCERATIVE COLITIS; COLITIS, ULCERATIVE; MICROBIOLOGY; PROCEDURES; TREATMENT OUTCOME;

COLITIS, ULCERATIVE; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; TREATMENT OUTCOME;

EID: 84964494885     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2017.04.001     Document Type: Erratum

References (53)

1. R.B. Sartor Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis Gastroenterology 139 2010 1816 1819
2. A. Neef, and Y. Sanz Future for probiotic science in functional food and dietary supplement development Curr Opin Clin Nutr Metab Care 16 2013 679 687
3. H. Sokol, B. Pigneur, L. Watterlot, and et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc Natl Acad Sci U S A 105 2008 16731 16736
4. J. Dicksved, J. Halfvarson, M. Rosenquist, and et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease ISME J 2 2008 716 727
5. D.N. Frank, A.L. St Amand, R.A. Feldman, and et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 2007 13780 13785
6. C. Manichanh, L. Rigottier-Gois, E. Bonnaud, and et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Gut 55 2006 205 211
7. G. Ianiro, A. Gasbarrini, and G. Cammarota Letter: faecal microbiota transplantation: not a one-size-fits-all approach Aliment Pharmacol Ther 40 2014 119
8. M. Rajilic-Stojanovic, F. Shanahan, F. Guarner, and W.M. de Vos Phylogenetic analysis of dysbiosis in ulcerative colitis during remission Inflamm Bowel Dis 19 2013 481 488
9. A.D. Kostic, R.J. Xavier, and D. Gevers The microbiome in inflammatory bowel disease: current status and the future ahead Gastroenterology 146 2014 1489 1499
10. S.J. Ott, S. Plamondon, A. Hart, and et al. Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse J Clin Microbiol 46 2008 3510 3513
11. J. Nishikawa, T. Kudo, S. Sakata, and et al. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis Scand J Gastroenterol 44 2009 180 186
12. A.W. Walker, J.D. Sanderson, C. Churcher, and et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease BMC Microbiol 11 2011 7
13. X.C. Morgan, T.L. Tickle, H. Sokol, and et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment Genome Biol 13 2012 R79
14. A. Fite, S. Macfarlane, E. Furrie, and et al. Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration J Clin Microbiol 51 2013 849 856
15. J. Kabeerdoss, V. Sankaran, S. Pugazhendhi, and B.S. Ramakrishna Clostridium leptum group bacteria abundance and diversity in the fecal microbiota of patients with inflammatory bowel disease: a case-control study in India BMC Gastroenterol 13 2013 20
16. K. Machiels, M. Joossens, J. Sabino, and et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis Gut 63 2014 1275 1283
17. W. Wang, L. Chen, R. Zhou, and et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease J Clin Microbiol 52 2014 398 406
18. R. Kumari, V. Ahuja, and J. Paul Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India World J Gastroenterol 19 2013 3404 3414
19. H. Sokol, P. Seksik, J.P. Furet, and et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota Inflamm Bowel Dis 15 2009 1183 1189
20. E. Varela, C. Manichanh, M. Gallart, and et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis Aliment Pharmacol Ther 38 2013 151 161
21. A. Swidsinski, A. Ladhoff, A. Pernthaler, and et al. Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
22. N.A. Nagalingam, and S.V. Lynch Role of the microbiota in inflammatory bowel diseases Inflamm Bowel Dis 18 2012 968 984
23. A. Andoh, S. Sakata, Y. Koizumi, and et al. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis Inflamm Bowel Dis 13 2007 955 962
24. A. Rehman, P. Lepage, A. Nolte, and et al. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients J Med Microbiol 59 2010 1114 1122
25. P. Lepage, R. Hasler, M.E. Spehlmann, and et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis Gastroenterology 141 2011 227 236
26. S. Michail, M. Durbin, D. Turner, and et al. Alterations in the gut microbiome of children with severe ulcerative colitis Inflamm Bowel Dis 18 2012 1799 1808
27. S.A. Walujkar, D.P. Dhotre, N.P. Marathe, and et al. Characterization of bacterial community shift in human ulcerative colitis patients revealed by Illumina-based 16S rRNA gene amplicon sequencing Gut Pathog 6 2014 22
28. M. Wang, G. Molin, S. Ahrne, and et al. High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes Dig Dis Sci 52 2007 620 627
29. H. Nemoto, K. Kataoka, H. Ishikawa, and et al. Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis Dig Dis Sci 57 2012 2955 2964
30. T. Ohkusa, N. Sato, T. Ogihara, and et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody J Gastroenterol Hepatol 17 2002 849 853
31. B. Kleessen, A.J. Kroesen, H.J. Buhr, and M. Blaut Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls Scand J Gastroenterol 37 2002 1034 1041
32. A. Lavelle, G. Lennon, O. O'Sullivan, and et al. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers Gut 64 2015 1553 1561
33. E. van Nood, A. Vrieze, M. Nieuwdorp, and et al. Duodenal infusion of donor feces for recurrent Clostridium difficile N Engl J Med 368 2013 407 415
34. I. Youngster, G.H. Russell, C. Pindar, and et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection JAMA 312 2014 1772 1778
35. Z. Kassam, C.H. Lee, Y. Yuan, and R.H. Hunt Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis Am J Gastroenterol 108 2013 500 508
36. G. Ianiro, S. Bibbo, F. Scaldaferri, and et al. Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement Medicine 93 2014 e97
37. R.J. Colman, and D.T. Rubin Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis J Crohn Colitis 8 2014 1569 1581
38. J.L. Anderson, R.J. Edney, and K. Whelan Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease Aliment Pharmacol Ther 36 2012 503 516
39. S. Kunde, A. Pham, S. Bonczyk, and et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis J Pediatr Gastroenterol Nutr 56 2013 597 601
40. Y. Wei, W. Zhu, J. Gong, and et al. Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease Gastroenterol Res Pract 2015 2015 517597
41. S.A. Kahn, R. Gorawara-Bhat, and D.T. Rubin Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we? Inflamm Bowel Dis 18 2012 676 684
42. S. Vermeire, M. Joossens, K. Verbeke, and et al. Donor species richness determines fecal microbiota transplantation success in inflammatory bowel disease J Crohn Colitis 2015
43. P. Moayyedi, M.G. Surette, P.T. Kim, and et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial Gastroenterology 149 2015 102 109
44. N.G. Rossen, S. Fuentes, M.J. van der Spek, and et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis Gastroenterology 149 2015 110 118
45. A.M. Grinspan, and C.R. Kelly Fecal microbiota transplantation for ulcerative colitis: not just yet Gastroenterology 149 2015 15 18
46. G. Cammarota, L. Masucci, and D. Currò Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases Dig Dis 2015 [In press.]
47. J.P. Ioannidis, and T.A. Trikalinos The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey CMAJ 176 2007 1091 1096
48. Y.A. Ghouri, D.M. Richards, E.F. Rahimi, and et al. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease Clin Exp Gastroenterol 7 2014 473 487
49. L.P. Smits, K.E. Bouter, W.M. de Vos, and et al. Therapeutic potential of fecal microbiota transplantation Gastroenterology 145 2013 946 953
50. L.J. Brandt American Journal of Gastroenterology Lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C difficile infection Am J Gastroenterol 108 2013 177 185
51. D. Tacke, H. Wisplinghoff, A. Kretzschmar, and et al. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe Clin Microbiol Infect 21 2015 e82 e84
52. N. Rossen, M. van der Spek, J. Hartman, and et al. Changes in faecal microbiota in UC patients after faecal microbiota transplantation J Crohn Colitis 9 2015 S73 S74
53. C.J. Damman, M.J. Brittnacher, M. Westerhoff, and et al. Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis PLoS One 10 2015 e0133925